Policy & oversight
New 2027 pay rules for dialysis care
Medicare proposed its 2027 payment update for dialysis clinics, a roughly 1 percent raise that also folds a common kidney drug into the standard payment. For the half million Americans on dialysis, this is the plumbing behind the chair.
By the Goodsurance editorial teamJune 29, 2026
Most Medicare news is about premiums and plans. This one is about the machinery that keeps a specific kind of care running. On June 26, 2026, Medicare proposed its payment rules for dialysis clinics for 2027. Medicare pays for almost everyone with end stage kidney disease, regardless of age, so these rules touch roughly half a million Americans who rely on dialysis to stay alive. The proposal would raise the base payment for a dialysis treatment from $281.71 to $299.55, an increase of about 1.1 percent across the roughly 7,600 clinics that provide this care, with Medicare expecting to pay about $6.2 billion in total. Part of that increase reflects a quieter change that matters to patients: oral phosphate binders, common drugs that people on dialysis take to control phosphorus levels, would be folded into the single bundled dialysis payment rather than billed separately. In plain terms, the clinic is paid one rate that is meant to cover the treatment and more of the related drugs together. None of this is something a patient signs up for or opts out of; it is the funding formula behind the care. Why pay attention at all? Because how clinics are paid shapes where they can operate and how steady that care is, especially in rural areas where a single clinic may be the only option for miles. The rule is a proposal open for public comment through August 24, 2026, not a final decision. The pointed framing about whether a 1 percent update keeps pace with real costs, and what it means for clinic consolidation, routes to my65checklist; here the job is simply to explain what changed and who it touches.
Medicare proposed its 2027 dialysis payment rules, a small raise that also folds a common kidney drug into the standard rate.
In plain words
Most Medicare news is about premiums and plans. This story is different. It is about how Medicare pays the clinics that give dialysis. Dialysis keeps people with failing kidneys alive. Medicare covers almost everyone who needs it, at any age. About half a million Americans count on it. On June 26, 2026, Medicare proposed how it will pay dialysis clinics in 2027. The base payment for one treatment would go up from $281.71 to $299.55, about 1 percent more. There are about 7,600 clinics, and Medicare expects to pay around $6.2 billion in all. One change matters to patients: a common kidney drug, called a phosphate binder, would be paid for as part of the dialysis payment instead of on its own. You do not sign up for any of this. It is the money behind the care. It matters because how clinics get paid affects where they can stay open, especially in country areas. This is just a proposal for now. People can comment until August 24, 2026.
Understand the basics first
Source: Centers for Medicare and Medicaid Services
Read at the source →